Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019

Abstract

In this longitudinal study of US insulin products, results suggest that insulin prices substantially increased from 2012 to 2015, even after accounting for discounts. The introduction of new insulin products was followed by substantial discounting practices that lowered net prices faced by payers.